Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit

Abstract
The present invention relates to a prosthetic knit based on at least a first yarn of biocompatible polymer material defining first and second opposite and openwork faces, and on at least a second biocompatible and heat-fusible monofilament yarn, forming barbs that protrude outwards from at least said first face and are obtained by melting loops generated by said second yarn, the chart followed for the knitting of said first and second yarns on a warp knitting machine having three guide bars B1, B2, B3 being the following, according to the ISO 11676 standard:—Bar B1: 1.0/0.1//—Bar B2: 1.0/7.7/6.6/7.78—Bar B3: 2.1/5.5/3.4/0.0// said second yarn following the chart of bar B3. The present invention also relates to a process for manufacturing such a knit.
Description

The present invention relates to a prosthetic knit equipped with barbs, capable of being rolled up on itself, then unrolled effortlessly. Such a knit can particularly be used for producing wall-reinforcing prostheses intended to be introduced into a patient by coelioscopy.


Wall-reinforcing prostheses, for example prostheses for reinforcing the abdominal wall, are widely used in the surgical field. These prostheses are intended to treat hernias by temporarily or permanently filling a tissue defect. These prostheses are generally made of biocompatible prosthetic fabric and can have a number of shapes, for example rectangular, circular or oval, depending on the anatomical structure to which they are to be fitted. Some of these prostheses are made from entirely bioresorbable yarns and are intended to disappear after having carried out their reinforcing role while cell colonization takes place and tissue rehabilitation takes over. Other prostheses comprise non-bioresorbable yarns and are intended to remain permanently in the body of the patient.


Some of these prostheses are made from an arrangement of yarns, a knit, a woven fabric or non-woven fabric, comprising barbs that protrude outwards from one face of the prosthesis: these barbs constitute hooks that are able to fix themselves either in another prosthetic fabric, belonging to the same prosthesis or not, or directly in the biological tissues, for example the abdominal wall.


Furthermore, for the sake of minimizing the traumatisms subsequent to any surgical operation, patients are increasingly often operated on via coelioscopic surgery when the type of operation carried out permits it. Coelioscopic surgery requires only very small incisions, through which a trocar is passed, within which the prosthesis is conveyed to the implantation site. Thus open surgery is avoided and the patient can leave hospital rapidly. Coelioscopic surgery is particularly popular in surgical operations carried out in the abdomen, such as for example the treatment of hernias.


However, the trocars used in coelioscopic surgery generally have a relatively small calibrated diameter, which may vary, for example, from 5 to 15 mm, in order to reduce the size of the incision made as much as possible. The prosthesis must therefore be conveyed within a channel of reduced diameter and it must then be deployed at the implantation site.


In order to carry out this step, the prosthesis is generally rolled up on itself in order to make it slide in the channel of the trocar or directly introduced by force. However, when the prosthetic fabric forming the prosthesis comprises barbs on one face, it may happen that these barbs become entangled in the body of the fabric and upset the subsequent deployment of the prosthesis at the implantation site. Furthermore, due to the fact that they are not protected, the barbs may be damaged during the unrolling of the prosthesis or during its transportation through the trocar to the implantation site.


Thus, there remains the need for a prosthetic fabric comprising barbs, that can be used for manufacturing prostheses, such as for example abdominal wall reinforcements, capable of being rolled up on itself in order to be conveyed within a channel such as that of a trocar, without damaging the barbs, and then capable of being completely deployed, and preferably in an easy manner, once it has reached the implantation site in the body of the patient.


The present invention aims to meet such a need.


A first aspect of the invention is a prosthetic knit based on at least a first yarn of biocompatible polymer material defining first and second opposite and openwork faces, and on at least a second biocompatible and heat-fusible monofilament yarn, forming barbs that protrude outwards from at least said first face and are obtained by melting loops generated by said second yarn, the chart followed for the knitting of said first and second yarns on a warp knitting machine having three guide bars B1, B2, B3 being the following, according to the ISO 11676 standard:

    • Bar B1: 1.0/0.1//
    • Bar B2: 1.0/7.7/6.6/7.7//
    • Bar B3: 2.1/5.5/3.4/0.0//
    • said second yarn following the chart of bar B3.


The knit according to the invention has both openwork faces, which favour cell recolonization, and barbs, suitable for hooking into biological tissues or any other textile, and an ability to be rolled up on itself, then unrolled effortlessly.


The knit according to the invention can be used as is in order to constitute a reinforcing prosthesis for repairing a hernia, or it may constitute one part of a reinforcing prosthesis for repairing hernias: for example, it may be partially or completely coated over part or all of its faces with a coating made of a biocompatible, for example non-stick, material; alternatively or in combination, the knit according to the invention may be combined with another textile in order to form a composite reinforcing prosthesis.


In the present application, the expression “openwork face” is understood to mean that said face comprises openings or pores: these openings or pores are in particular generated by the chart followed for the knitting of the yarns of the knit according to the invention, and may correspond to the various meshes of said knit.


The barbs of the knit according to the invention may protrude from the first face substantially perpendicular to the plane of said face or alternatively along one or more planes that are inclined relative to the plane of said face. These barbs are intended to function as fastening means, either by becoming entangled in one or more arrangements of yarns, fibres, filaments and/or multifilaments of another prosthetic fabric, for example in order to form a composite reinforcing prosthesis, or by anchoring directly in the biological tissues, such as for example an abdominal wall, once the prosthesis comprising this knit or constituted of this knit is implanted. Generally, these barbs have the shape of a shaft, having the diameter of the yarn used for their formation, surmounted by a head having a diameter greater than that of the shaft.


In the knit according to the invention, the chart followed for the knitting of the yarns of the knit generates a particular structure of the knit, that is to say a specific arrangement between the various openings of the faces of the knit, the respective size of these various openings and the position and distribution of the barbs being such that, even if some of the barbs present on the first face are caused to be trapped within some of the openings present on the second face when the knit is rolled up on itself under the effect of an external stress, such as for example the stress exerted by the surgeon when he rolls the knit or the prosthesis comprising the knit up on itself in order to introduce it into a trocar, and subsequently the stress exerted by the internal walls of the trocar, then a large number of the barbs trapped will be released automatically, or under the effect of a very small unrolling force, when said stress is relieved.


The knit according to the invention can be used to produce a reinforcing prosthesis for repairing a hernia. Thus, when the surgeon wishes to implant a prosthesis formed of a knit according to the invention, he can easily roll the knit up on itself, for example by folding the face provided with barbs outwards. It is then possible to introduce the knit according to the invention, thus rolled up, into a trocar, for example having an internal diameter of 10 mm. Once the knit according to the invention has been thus conveyed in the form of a roll to the implantation site via the trocar, it can be unrolled and deployed easily: indeed, even if some of the barbs were trapped within some of the openings present on the second face of the knit during the rolling up of the knit according to the invention and during its passage in the trocar, the particular structure of the knit according to the invention obtained by means of the particular chart followed during the knitting of the knit according to the invention means that these trapped barbs can be released very easily by exerting a minimal force for unrolling the knit. Thus, even if the barbs were entangled when the prosthesis was rolled up, they can be easily disentangled, and the surgeon can deploy the knit and/or the prosthesis easily in order to position it correctly on the implantation site.


The knit can then be fastened either to another fabric, or to a biological wall, owing to the anchoring abilities of the barbs.


In one embodiment of the invention, the first yarn or yarns are monofilament yarns. The first yarn or yarns of the knit according to the invention are those that follow the charts of bars B1 and B2. They constitute the ground structure or alternatively the base of the knit according to the invention, since the second yarn, namely a heat-fusible monofilament yarn, so as to generate the barbs, is regularly cut at the loops that it forms. The generation of barbs from loops made of heat-fusible yarn is known and is described, for example in document WO 01/81667. When the first yarn or yarns are monofilament yarns, the possible presence of protrusions or anchorage points of the barbs is limited and the force needed to unroll the knit after the rolling up as described above is very small.


The first yarns of the knit according to the invention may be made of any biodegradable or non-biodegradable biocompatible material. Thus, the biodegradable materials suitable for the first yarns of the knit of the present invention may be selected from polylactic acid (PLA), polyglycolic acid (PGA), oxidized cellulose, polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoates (PHAs), copolymers thereof and mixtures thereof. The non-biodegradable materials suitable for the first yarns of the knit of the present invention may be selected from polyethylene terephthalate (PET), polyamides, aramids, expanded polytetrafluoroethylene, polyurethane, polyvinylidene difluoride (PVDF), butyl ester polymers, polyetheretherketone (PEEK), polyolefins (such as polyethylene or polypropylene), polyethers, copper alloys, silver or platinum alloys, medical grades of steel such as medical-grade stainless steel, and combinations thereof.


In one embodiment of the invention, the first yarns are monofilament yarns made of polyester terephthalate (PET) having a diameter of 0.09 mm. Such yarns have an intrinsic stiffness meaning that when these yarns follow the particular charts of bars B1 and B2 of the knit according to the present invention, the knit obtained naturally tends to return to a flat configuration when it is unrolled under the effect of a stress as described above.


The second heat-fusible monofilament yarn may be made of a bioresorbable or non-bioresorbable material. For example, the heat-fusible monofilament yarn is made of a material selected from polypropylene, polyglycolic acid, polylactic acid, and mixtures thereof. In one embodiment, the heat-fusible monofilament yarn is a polylactic acid monofilament yarn having a diameter of 0.15 mm: such a yarn having such a diameter makes it possible to obtain barbs that have good anchoring abilities in biological tissues or in another openwork textile, while maintaining the ability of the knit according to the invention to be unrolled easily.


Another aspect of the invention is a process for manufacturing a prosthetic knit as described above, comprising the following steps:

    • i) knitting, on a warp knitting machine, of biocompatible yarns distributed over three guide bars, according to the following chart, according to the ISO 11676 standard:
    • Bar B1: 1.0/0.1//
    • Bar B2: 1.0/7.7/6.6/7.7//
    • Bar B3: 2.1/5.5/3.4/0.0//
    • the yarn threaded on bar B3 being a heat-fusible monofilament yarn that generates loops that protrude outwards with respect to said first face,
    • ii) cutting, by melting, of each loop, each loop thus generating two barbs.


In the process according to the invention the yarns threaded on bar B1 and bar B2 are the first yarns made of biocompatible polymer material: these yarns may be identical or different. Thus, as seen above, these yarns may be monofilament yarns, in particular monofilament yarns made of polyester terephthalate (PET) having a diameter of 0.09 mm.


In one embodiment of the invention, the yarns are threaded one full, one empty on bars B1 and B2, and one full, three empty on bar B3.


Another aspect of the invention is a knit capable of being obtained according to the above process.


Another aspect of the invention is a prosthesis for repairing a hernia, comprising a knit as described above or obtained according to the process described above.


The knit according to the invention and/or the prosthesis according to the invention may be used in a method for treating a hernia, in particular the abdominal wall. The knit and the prosthesis according to the invention are particularly suitable for coelioscopic or laparoscopic surgery.





The advantages of the present invention are illustrated by means of the experimental section which follows and the following supporting figures:



FIGS. 1A to 1C: are diagrams showing the charts followed for the knitting of the yarns of the knits according to the invention,



FIG. 2: is a diagram showing a chart followed for the knitting of the yarns of a knit from the prior art,



FIG. 3: is a diagram illustrating the method for rolling up a knit,



FIGS. 4A and 4B: are diagrams illustrating the test for evaluating the force for unrolling a rolled-up knit,



FIG. 5: shows the curve representing the force applied, in N, as a function of the extension, in mm, of a knit during the unrolling thereof.





EXAMPLE 1

Produced on a warp knitting machine having three guide bars B1, B2 and B3, were a knit A, according to the invention, and a comparative knit B, the chart of which differs from that of the knit according to the invention.


Knit A: according to the invention, having the following chart according to the ISO 11676 standard:

    • Bar B1: 1.0/0.1//
    • Bar B2: 1.0/7.7/6.6/7.7//
    • Bar B3: 2.1/5.5/3.4/0.0//


These charts are illustrated in FIGS. 1A to 1C according to a representation known to a person skilled in the art: the chart of bar B1 is illustrated in FIG. 1A; the chart of bar B2 is illustrated in FIG. 1B and the chart of bar B3 is illustrated in FIG. 1C.


Bar B1 and bar B2 are each threaded 1 full, 1 empty, with a monofilament yarn made of polyester terephthalate (PET) having a diameter of 0.09 mm; bar B3, which gives rise to the barbs, is threaded 1 full, 3 empty, with a heat-fusible monofilament yarn made of polylactic acid having a diameter of 0.15 mm.


Knit B: comparative, having the following chart according to the ISO 11676 standard:

    • Bar B1: 1.0/0.1//
    • Bar B2: 1.0.0/5.5/1.0/3.3//
    • Bar B3: 2.1/5.5/3.4/0.0//


The chart of bar B2 is illustrated in FIG. 2.


Bar B1 and bar B2 are each threaded 1 full, 1 empty, with a monofilament yarn made of polyester terephthalate (PET) having a diameter of 0.08 mm; bar B3, which gives rise to the barbs, is threaded 1 full, 3 empty, with a heat-fusible monofilament yarn made of polylactic acid having a diameter of 0.15 mm.


For each of the two knits A and B, bar B3 is the one that leads to the formation of the barbs. Since the bars B3 are threaded in an identical manner for the two knits, and these bars have the same chart, the density of the barbs, once the loops have been melted, is the same for both knits.


Once the loops have been melted and the barbs have been formed as described in WO 01/81667, the unrolling properties were evaluated after rolling these knits up on themselves, according to the following test:

    • for each knit, samples of 5 cm×10 cm were cut,
    • as shown in FIG. 3, each sample 1 of knit is rolled up on itself around a rod 3 having a diameter of 5 mm, the barbs 2 on the outside, along the direction of the arrow represented in FIG. 3. The roll obtained is then grasped with tweezers and inserted into a trocar having an internal diameter of 10 mm, then pushed until it comes out of the trocar.


On exiting the trocar, as shown in FIG. 4A, the sample 1 in the form of a roll is mounted on a machine 4 equipped with a cell loaded to 25 N, comprising a fixed part 5 and a moving part 6. Around 2 cm of the sample 1 is unrolled and 1 cm of the sample 1 is fastened to the moving part 6. A constant extension rate of 50 mm/min is then applied to the sample 1 tested in order to unroll it, and the corresponding force F needed to maintain said constant extension rate is measured. The force F needed is recorded as a function of the length L of the unrolled portion of the sample 1 until sample 1 is completely unrolled, as shown in FIG. 4B. During the unrolling of the sample 1, the force force F needed may vary as a function of the resistance encountered. In particular, points of resistance, for which the force F for successfully unrolling the sample 1 must be increased, at least occasionally, may appear during the unrolling.


These “points of resistance” are measured as follows: using measured values of the force F and length L of the unrolled portion as indicated above, the curve representing the force F, in newtons, is plotted as a function of the length L of the unrolled portion in mm, of the sample 1. Next, a threshold value is determined for the force F, for example 0.5 N. Each peak of the curve having a value greater than 0.5 N is considered to be a point of resistance. An example of such a curve, showing the peaks counted encircled, is represented in FIG. 5. By virtue of this curve, the maximum force needed, Fmax, is also determined.


The results obtained for knit A according to the invention and comparative knit B are presented in Table I below:













TABLE I







Number of





Number of
“points of
Average
Maximum


Sample
tests
resistance”
force (N)
force (N)







Knit A
16
52 ± 11
1.13 ± 0.33
3.54 ± 0.85


Knit B
20
79 ± 8 
4.01 ± 0.80
9.56 ± 1.68









As it emerges from this table, the knit according to the invention (Knit A) has significantly fewer points of resistance than the knit from the prior art (Knit B). The average force needed to unroll the knit of the invention, after it has been rolled up on itself then passed through a trocar having an internal diameter of 10 mm is substantially lower than that needed to unroll the knit from the prior art. Likewise, the maximum force needed to unroll knit A according to the invention is practically divided by 3 compared to the maximum force needed in the case of the comparative knit B.


Thus, the knit according to the invention can be unrolled easily after having been rolled up on itself then passed through a trocar having a diameter of 10 mm. The knit can thus be brought to an implantation site during laparoscopic or coelioscopic surgery for repairing a hernia, by means of a trocar, then it can be unrolled without the surgeon having to apply considerable force in order to deploy the knit and/or the prosthesis comprising said knit.

Claims
  • 1. A prosthetic knit comprising at least a first monofilament yarn of biocompatible polymer material defining first and second opposite faces, said first face including barbs protruding substantially perpendicular to a plane of the first face and said second face including openings, wherein the openings and the barbs are distributed such that when the knit is rolled upon itself at least some of the barbs present on the first face are caused to be trapped within some of the openings on the second face, wherein the openings and the barbs are distributed such that the knit experiences a number of points of resistance of 52±11 when the knit is unrolled at a constant extension rate.
  • 2. The prosthetic knit according to claim 1, wherein the barbs include a shaft and a head wherein a diameter of the head is greater than a diameter of the shaft.
  • 3. The prosthetic knit according to claim 2, wherein the barbs are made of a bioresorbable material.
  • 4. The prosthetic knit according to claim 3, wherein the first monofilament yarn is made of polyester terephthalate (PET) having a diameter of 0.09 mm.
  • 5. The prosthetic knit according to claim 1, further comprising a second textile.
  • 6. The prosthetic knit according to claim 1, wherein the barbs are not damaged after unrolling.
  • 7. The prosthetic knit according to claim 1, further comprising a non-stick coating made of a biocompatible material.
  • 8. The prosthetic knit according to claim 1, wherein the first face includes openings.
  • 9. The prosthetic knit according to claim 1, wherein the constant extension rate is 50 mm/min.
  • 10. The prosthetic knit according to claim 1, wherein the number of points of resistance is per 50 cm2 of the first face of the knit.
  • 11. A method for hernia repair comprising rolling a prosthetic knit up on itself, the knit including at least a first monofilament yarn of biocompatible polymer material defining first and second opposite faces, said first face including barbs protruding substantially perpendicular to a plane of the first face and said second face including openings, wherein the openings and the barbs are distributed such that at least some of the barbs present on the first face are caused to be trapped within some of the openings on the second face during rolling of the prosthetic knit, wherein the openings and the barbs are distributed such that the knit experiences a number of points of resistance of 52±11 when the knit is unrolled at a constant extension rateconveying the rolled knit to a site of implantation, andunrolling the knit and releasing the trapped barbs from the openings to attach to tissue.
  • 12. The method according to claim 11, further comprising introducing the rolled knit into a trocar prior to conveying the rolled knit to the site of implantation.
  • 13. The method according to claim 11, wherein the barbs include a shaft and a head wherein a diameter of the head is greater than a diameter of the shaft.
  • 14. The method according to claim 13, wherein the barbs are made of a bioresorbable material.
  • 15. The method according to claim 11, wherein the first monofilament yarn is made of polyester terephthalate (PET) having a diameter of 0.09 mm.
  • 16. The method according to claim 11, wherein the prosthetic knit further includes a second textile.
  • 17. The method according to claim 11, wherein the barbs are not damaged after unrolling.
  • 18. The method according to claim 11, wherein the constant extension rate is 50 mm/min.
  • 19. The method according to claim 11, wherein the number of points of resistance is per 50 cm2 of the first face of the knit.
Priority Claims (1)
Number Date Country Kind
11/62535 Dec 2011 FR national
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/436,979 filed on Jun. 11, 2019, now U.S. Pat. No. 11,266,489, which is continuation of U.S. patent application Ser. No. 15/262,165 filed on Sep. 12, 2016, now U.S. Pat. No. 10,342,652, which is a continuation of U.S. patent application Ser. No. 14/366,393 filed Jun. 18, 2014, now U.S. Pat. No. 9,445,883, which is a National Stage Application of PCT/EP2012/076981 filed Dec. 27, 2012, which claims the benefit of and priority to French Patent Application Serial No. 1162535 filed on Dec. 29, 2011, the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.

US Referenced Citations (337)
Number Name Date Kind
1187158 Mcginley Jun 1916 A
3118294 Laethem Jan 1964 A
3124136 Usher Mar 1964 A
3272204 Artandi et al. Sep 1966 A
3276448 Kronenthal Oct 1966 A
3320649 Naimer May 1967 A
3364200 Ashton et al. Jan 1968 A
3570482 Shigeru et al. Mar 1971 A
4006747 Kronenthal et al. Feb 1977 A
4060081 Yannas et al. Nov 1977 A
4173131 Melton et al. Nov 1979 A
4193137 Heck Mar 1980 A
4248064 Odham Feb 1981 A
4294241 Miyata Oct 1981 A
4307717 Hymes et al. Dec 1981 A
4338800 Matsuda Jul 1982 A
4476697 Unknown Oct 1984 A
4487865 Balazs et al. Dec 1984 A
4500676 Balazs et al. Feb 1985 A
4511653 Play et al. Apr 1985 A
4527404 Nakagaki et al. Jul 1985 A
4591501 Cioca May 1986 A
4597762 Walter et al. Jul 1986 A
4603695 Ikada et al. Aug 1986 A
4631932 Sommers Dec 1986 A
4670014 Huc et al. Jun 1987 A
4709562 Matsuda Dec 1987 A
4748078 Doi et al. May 1988 A
4759354 Quarfoot Jul 1988 A
4769038 Bendavid et al. Sep 1988 A
4796603 Dahlke et al. Jan 1989 A
4813942 Alvarez Mar 1989 A
4841962 Berg et al. Jun 1989 A
4846815 Scripps Jul 1989 A
4854316 Davis Aug 1989 A
4925294 Geshwind et al. May 1990 A
4931546 Tardy et al. Jun 1990 A
4942875 Hlavacek et al. Jul 1990 A
4948540 Nigam Aug 1990 A
4950483 Ksander et al. Aug 1990 A
4970298 Silver et al. Nov 1990 A
5002551 Linsky et al. Mar 1991 A
5147374 Fernandez Sep 1992 A
5162430 Rhee et al. Nov 1992 A
5171273 Silver et al. Dec 1992 A
5176692 Wilk et al. Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5196185 Silver et al. Mar 1993 A
5201745 Tayot et al. Apr 1993 A
5201764 Kelman et al. Apr 1993 A
5206028 Li Apr 1993 A
5217493 Raad et al. Jun 1993 A
5254133 Seid Oct 1993 A
5256418 Kemp et al. Oct 1993 A
5263983 Yoshizato et al. Nov 1993 A
5304595 Rhee et al. Apr 1994 A
5306500 Rhee et al. Apr 1994 A
5324775 Rhee et al. Jun 1994 A
5328955 Rhee et al. Jul 1994 A
5334527 Brysk Aug 1994 A
5339657 Mcmurray Aug 1994 A
5350583 Yoshizato et al. Sep 1994 A
5356432 Rutkow et al. Oct 1994 A
5368549 Mcvicker Nov 1994 A
5376375 Rhee et al. Dec 1994 A
5376376 Li Dec 1994 A
5397331 Himpens et al. Mar 1995 A
5399361 Song et al. Mar 1995 A
5413791 Rhee et al. May 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5428022 Palefsky et al. Jun 1995 A
5433996 Kranzler et al. Jul 1995 A
5441491 Verschoor et al. Aug 1995 A
5441508 Gazielly et al. Aug 1995 A
5456693 Conston et al. Oct 1995 A
5456711 Hudson Oct 1995 A
5466462 Rosenthal et al. Nov 1995 A
5480644 Freed Jan 1996 A
5487895 Dapper et al. Jan 1996 A
5490984 Freed Feb 1996 A
5512291 Li Apr 1996 A
5512301 Song et al. Apr 1996 A
5514181 Light et al. May 1996 A
5522840 Krajicek Jun 1996 A
5523348 Rhee et al. Jun 1996 A
5536656 Kemp et al. Jul 1996 A
5543441 Rhee et al. Aug 1996 A
5565210 Rosenthal et al. Oct 1996 A
5567806 Abdul-Malak et al. Oct 1996 A
5569273 Titone et al. Oct 1996 A
RE35399 Eisenberg Dec 1996 E
5593441 Lichtenstein et al. Jan 1997 A
5595621 Light et al. Jan 1997 A
5601571 Moss Feb 1997 A
5607474 Athanasiou et al. Mar 1997 A
5607590 Shimizu Mar 1997 A
5614587 Rhee et al. Mar 1997 A
5618551 Tardy et al. Apr 1997 A
5634931 Kugel Jun 1997 A
5639796 Lee Jun 1997 A
5665391 Lea Sep 1997 A
5667839 Berg Sep 1997 A
5681568 Goldin et al. Oct 1997 A
5686115 Vournakis et al. Nov 1997 A
5690675 Sawyer et al. Nov 1997 A
5695525 Mulhauser et al. Dec 1997 A
5697978 Sgro Dec 1997 A
5700476 Rosenthal et al. Dec 1997 A
5700477 Rosenthal et al. Dec 1997 A
5709934 Bell et al. Jan 1998 A
5716409 Debbas Feb 1998 A
5720981 Eisinger Feb 1998 A
5732572 Litton Mar 1998 A
5749895 Sawyer et al. May 1998 A
5752974 Rhee et al. May 1998 A
5766246 Mulhauser et al. Jun 1998 A
5766631 Arnold Jun 1998 A
5769864 Kugel Jun 1998 A
5771716 Schlussel Jun 1998 A
5785983 Furlan et al. Jul 1998 A
5800541 Rhee et al. Sep 1998 A
5814328 Gunasekaran Sep 1998 A
5833705 Ken et al. Nov 1998 A
5840011 Landgrebe et al. Nov 1998 A
5861034 Taira et al. Jan 1999 A
5863984 Doillon et al. Jan 1999 A
5869080 Mcgregor et al. Feb 1999 A
5871767 Pionne et al. Feb 1999 A
5876444 Lai Mar 1999 A
5891558 Bell et al. Apr 1999 A
5899909 Claren et al. May 1999 A
5906937 Sugiyama et al. May 1999 A
5910149 Kuzmak Jun 1999 A
5911731 Pham et al. Jun 1999 A
5916225 Kugel Jun 1999 A
5919232 Chaffringeon et al. Jul 1999 A
5919233 Knopf et al. Jul 1999 A
5922026 Chin Jul 1999 A
5931165 Reich et al. Aug 1999 A
5942278 Hagedorn et al. Aug 1999 A
5962136 Dewez et al. Oct 1999 A
5972022 Huxel Oct 1999 A
RE36370 Li Nov 1999 E
5993844 Abraham et al. Nov 1999 A
5994325 Roufa et al. Nov 1999 A
5997895 Narotam et al. Dec 1999 A
6001895 Harvey et al. Dec 1999 A
6008292 Lee et al. Dec 1999 A
6015844 Harvey et al. Jan 2000 A
6039686 Robert Mar 2000 A
6042534 Gellman et al. Mar 2000 A
6042592 Schmitt Mar 2000 A
6043089 Sugiyama et al. Mar 2000 A
6051425 Morota et al. Apr 2000 A
6056688 Benderev et al. May 2000 A
6056970 Greenawalt et al. May 2000 A
6057148 Sugiyama et al. May 2000 A
6063396 Kelleher May 2000 A
6066776 Goodwin et al. May 2000 A
6066777 Benchetrit May 2000 A
6071292 Makower et al. Jun 2000 A
6077281 Das Jun 2000 A
6080194 Pachence et al. Jun 2000 A
6083522 Chu et al. Jul 2000 A
6120539 Eldridge et al. Sep 2000 A
6132765 Dicosmo et al. Oct 2000 A
6143037 Goldstein et al. Nov 2000 A
6153292 Bell et al. Nov 2000 A
6165488 Tardy et al. Dec 2000 A
6171318 Kugel et al. Jan 2001 B1
6174320 Kugel et al. Jan 2001 B1
6176863 Kugel et al. Jan 2001 B1
6179872 Bell et al. Jan 2001 B1
6197325 Macphee et al. Mar 2001 B1
6197934 Devore et al. Mar 2001 B1
6197935 Doillon et al. Mar 2001 B1
6210439 Firmin et al. Apr 2001 B1
6221109 Geistlich et al. Apr 2001 B1
6224616 Kugel May 2001 B1
6241768 Agarwal et al. Jun 2001 B1
6258124 Darois et al. Jul 2001 B1
6262332 Ketharanathan Jul 2001 B1
6264702 Ory et al. Jul 2001 B1
6267772 Mulhauser et al. Jul 2001 B1
6277397 Shimizu Aug 2001 B1
6280453 Kugel et al. Aug 2001 B1
6287316 Agarwal et al. Sep 2001 B1
6290708 Kugel et al. Sep 2001 B1
6306424 Vyakarnam et al. Oct 2001 B1
6312474 Francis et al. Nov 2001 B1
6328686 Robert Dec 2001 B1
6334872 Termin et al. Jan 2002 B1
6383201 Dong May 2002 B1
6391333 Li et al. May 2002 B1
6391939 Tayot et al. May 2002 B2
6408656 Ory et al. Jun 2002 B1
6410044 Chudzik et al. Jun 2002 B1
6413742 Olsen et al. Jul 2002 B1
6428978 Olsen et al. Aug 2002 B1
6436030 Rehil Aug 2002 B2
6440167 Shimizu Aug 2002 B2
6443964 Ory et al. Sep 2002 B1
6447551 Goldmann Sep 2002 B1
6447802 Sessions et al. Sep 2002 B2
6448378 Devore et al. Sep 2002 B2
6451032 Ory et al. Sep 2002 B1
6451301 Sessions et al. Sep 2002 B1
6454787 Maddalo et al. Sep 2002 B1
6477865 Matsumoto Nov 2002 B1
6479072 Morgan et al. Nov 2002 B1
6500464 Ceres et al. Dec 2002 B2
6509031 Miller et al. Jan 2003 B1
6511958 Atkinson et al. Jan 2003 B1
6514286 Leatherbury et al. Feb 2003 B1
6514514 Atkinson et al. Feb 2003 B1
6540773 Dong Apr 2003 B2
6541023 Andre et al. Apr 2003 B1
6548077 Gunasekaran Apr 2003 B1
6554855 Dong Apr 2003 B1
6559119 Burgess et al. May 2003 B1
6566345 Miller et al. May 2003 B2
6575988 Rousseau Jun 2003 B2
6576019 Atala Jun 2003 B1
6596002 Therin et al. Jul 2003 B2
6596304 Bayon et al. Jul 2003 B1
6599323 Melican et al. Jul 2003 B2
6599524 Li et al. Jul 2003 B2
6599690 Abraham et al. Jul 2003 B1
6613348 Jain Sep 2003 B1
6623963 Mueller et al. Sep 2003 B1
6630414 Matsumoto Oct 2003 B1
6638284 Rousseau et al. Oct 2003 B1
6652594 Francis et al. Nov 2003 B2
6653450 Berg et al. Nov 2003 B1
6656206 Corcoran et al. Dec 2003 B2
6660280 Allard et al. Dec 2003 B1
6669735 Pelissier Dec 2003 B1
6682760 Noff et al. Jan 2004 B2
6685714 Rousseau Feb 2004 B2
6706684 Bayon et al. Mar 2004 B1
6706690 Reich et al. Mar 2004 B2
6719795 Bryan et al. Apr 2004 B1
6723335 Moehlenbruck et al. Apr 2004 B1
6730299 Tayot et al. May 2004 B1
6736823 Darois et al. May 2004 B2
6743435 Devore et al. Jun 2004 B2
6755868 Rousseau Jun 2004 B2
6773723 Spiro et al. Aug 2004 B1
6783554 Amara et al. Aug 2004 B2
6790213 Cherok et al. Sep 2004 B2
6790454 Abdul et al. Sep 2004 B1
6800082 Rousseau Oct 2004 B2
6833408 Sehl et al. Dec 2004 B2
6835336 Watt Dec 2004 B2
6852330 Bowman et al. Feb 2005 B2
6869938 Schwartz et al. Mar 2005 B1
6893653 Abraham et al. May 2005 B2
6896904 Spiro et al. May 2005 B2
6936276 Spiro et al. Aug 2005 B2
6939562 Spiro et al. Sep 2005 B2
6949625 Tayot Sep 2005 B2
6966918 Schuldt-Hempe et al. Nov 2005 B1
6971252 Therin et al. Dec 2005 B2
6974679 Andre et al. Dec 2005 B2
6974862 Ringeisen et al. Dec 2005 B2
6977231 Matsuda Dec 2005 B1
6988386 Okawa et al. Jan 2006 B1
7025063 Snitkin et al. Apr 2006 B2
7041868 Greene et al. May 2006 B2
RE39172 Bayon et al. Jul 2006 E
7098315 Schaufler Aug 2006 B2
7101381 Ford et al. Sep 2006 B2
7115220 Dubson et al. Oct 2006 B2
7156858 Schuldt-Hempe et al. Jan 2007 B2
7175852 Simmoteit et al. Feb 2007 B2
7192604 Brown et al. Mar 2007 B2
7207962 Anand et al. Apr 2007 B2
7214765 Ringeisen et al. May 2007 B2
7226611 Yura et al. Jun 2007 B2
7229453 Anderson et al. Jun 2007 B2
7594921 Browning Sep 2009 B2
7615065 Priewe et al. Nov 2009 B2
7670380 Cauthen, III Mar 2010 B2
7709017 Tayot et al. May 2010 B2
7718556 Matsuda et al. May 2010 B2
7732354 Fricke et al. Jun 2010 B2
7785334 Ford et al. Aug 2010 B2
7799767 Lamberti et al. Sep 2010 B2
7806905 Ford et al. Oct 2010 B2
7824420 Eldridge et al. Nov 2010 B2
7846171 Kullas et al. Dec 2010 B2
7905825 Arnal et al. Mar 2011 B2
8142515 Therin et al. Mar 2012 B2
8197837 Jamiolkowski et al. Jun 2012 B2
8323675 Greenawalt Dec 2012 B2
8366787 Brown et al. Feb 2013 B2
8418508 Lecuivre et al. Apr 2013 B2
8709094 Stad et al. Apr 2014 B2
8834578 Bayon et al. Sep 2014 B2
8834864 Odar et al. Sep 2014 B2
8846060 Archibald et al. Sep 2014 B2
8877233 Obermiller et al. Nov 2014 B2
8956373 Ford et al. Feb 2015 B2
8961850 Wood et al. Feb 2015 B2
9034357 Stopek May 2015 B2
9398943 Criscuolo et al. Jul 2016 B2
9445883 Lecuivre et al. Sep 2016 B2
10342652 Lecuivre et al. Jul 2019 B2
10865505 Montanari et al. Dec 2020 B2
11266489 Lecuivre Mar 2022 B2
20020095218 Carr et al. Jul 2002 A1
20030086975 Ringeisen May 2003 A1
20030114937 Leatherbury et al. Jun 2003 A1
20030133967 Ruszczak et al. Jul 2003 A1
20030225355 Butler Dec 2003 A1
20040034373 Schuldt-Hempe et al. Feb 2004 A1
20040059356 Gingras Mar 2004 A1
20040101546 Gorman et al. May 2004 A1
20050002893 Goldmann Jan 2005 A1
20050021058 Negro Jan 2005 A1
20050085924 Darois et al. Apr 2005 A1
20050113849 Popadiuk et al. May 2005 A1
20050137512 Campbell et al. Jun 2005 A1
20050142161 Freeman et al. Jun 2005 A1
20050148963 Brennan Jul 2005 A1
20050175659 Macomber et al. Aug 2005 A1
20050232979 Shoshan Oct 2005 A1
20050267521 Forsberg Dec 2005 A1
20050288691 Leiboff Dec 2005 A1
20060135921 Wiercinski et al. Jun 2006 A1
20060147501 Hillas et al. Jul 2006 A1
20060216320 Kitazono et al. Sep 2006 A1
20060252981 Matsuda et al. Nov 2006 A1
20070299538 Roeber Dec 2007 A1
20090192532 Spinnler et al. Jul 2009 A1
20130172915 Thomas et al. Jul 2013 A1
20140228867 Thomas et al. Aug 2014 A1
Foreign Referenced Citations (95)
Number Date Country
1317836 May 1993 CA
19544162 Apr 1997 DE
10019604 Oct 2001 DE
10043396 Jun 2002 DE
0194192 Sep 1986 EP
0248544 Dec 1987 EP
0276890 Aug 1988 EP
0372969 Jun 1990 EP
0544485 Jun 1993 EP
0552576 Jul 1993 EP
0614650 Sep 1994 EP
0621014 Oct 1994 EP
0625891 Nov 1994 EP
0637452 Feb 1995 EP
0705878 Apr 1996 EP
0719527 Jul 1996 EP
0774240 May 1997 EP
0797962 Oct 1997 EP
0827724 Mar 1998 EP
0836838 Apr 1998 EP
0895762 Feb 1999 EP
0898944 Mar 1999 EP
1017415 Jul 2000 EP
1052319 Nov 2000 EP
1055757 Nov 2000 EP
1216717 Jun 2002 EP
1216718 Jun 2002 EP
0693523 Nov 2002 EP
1315468 Jun 2003 EP
1382728 Jan 2004 EP
1484070 Dec 2004 EP
1561480 Aug 2005 EP
1782848 May 2007 EP
2244853 Apr 1975 FR
2257262 Aug 1975 FR
2308349 Nov 1976 FR
2453231 Oct 1980 FR
2715405 Jul 1995 FR
2724563 Mar 1996 FR
2744906 Aug 1997 FR
2766698 Feb 1999 FR
2771622 Jun 1999 FR
2779937 Dec 1999 FR
2859624 Dec 2005 FR
2863277 Jun 2006 FR
2884706 Apr 2008 FR
2051153 Jan 1981 GB
H0332677 Mar 1991 JP
H05237128 Sep 1993 JP
H09137380 May 1997 JP
9532687 Dec 1995 NO
9906080 Feb 1999 NO
8902445 Mar 1989 WO
8908467 Sep 1989 WO
9012551 Nov 1990 WO
9206639 Apr 1992 WO
9220349 Nov 1992 WO
9311805 Jun 1993 WO
9318174 Sep 1993 WO
9417747 Aug 1994 WO
9507666 Mar 1995 WO
9518638 Jul 1995 WO
9603091 Feb 1996 WO
9608277 Mar 1996 WO
9609795 Apr 1996 WO
9614805 May 1996 WO
9641588 Dec 1996 WO
9735533 Oct 1997 WO
9835632 Aug 1998 WO
9849967 Nov 1998 WO
9905990 Feb 1999 WO
9906079 Feb 1999 WO
9951163 Oct 1999 WO
0016821 Mar 2000 WO
0067663 Nov 2000 WO
0115625 Mar 2001 WO
0180773 Nov 2001 WO
0181667 Nov 2001 WO
0207648 Jan 2002 WO
02078568 Oct 2002 WO
03002168 Jan 2003 WO
2004004600 Jan 2004 WO
2004071349 Aug 2004 WO
2004078120 Sep 2004 WO
2004103212 Dec 2004 WO
2005011280 Feb 2005 WO
2005013863 Feb 2005 WO
2005018698 Mar 2005 WO
2005105172 Nov 2005 WO
2006018552 Feb 2006 WO
2006023444 Mar 2006 WO
2009071998 Jun 2009 WO
2009031035 Jan 2010 WO
2007048099 Sep 2010 WO
2011027087 Mar 2011 WO
Non-Patent Literature Citations (33)
Entry
Amid, P., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003.
Australian Patent Examination Report dated Aug. 15, 2016 in corresponding Australian Patent Application No. 2012360855, 2 pages.
Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4).
Blondin, C. et al., “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6).
Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1).
Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004.
Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical Materials Research, Feb. 1991, pp. 267-276, vol. 25.
Communication pursurant to Article 94(3) EPC issued in European Patent Application No. 19154116.8 dated Jan. 13, 2022, 7 pages.
Ellouali, M. et al., “Antitumor Activity of Low Molecular Weight Fucans Extracted from Brown Seaweed Ascophyllu hodosum,” Anticancer Res., Nov.-Dec. 1993, pp. 2011-2020, 12 (6A).
Extended European Search Report issued in EP Patent Application No. 19154116.8 dated Jun. 6, 2019, 6 pages.
Haneji, K et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, pp. 189-201, 52(2), published online Nov. 2009.
Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4).
Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5).
Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19.
International Search Report for PCT/EP12/076981 date of completion is Apr. 16, 2013 (2 pages).
Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg. Sep. 2002, pp. 1472-1480, 26.
Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle, ” Br. J. Pharmacol., Oct. 2005, pp. 370-777, 146(3).
Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165.
Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J. Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63.
Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17 (7).
Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4).
Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36.
Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10.
O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2).
Preliminary Search Report from French Patent Office dated Dec. 20, 2006, 3 pages.
Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136.
Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34.
Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007.
Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004, pp. 211-220, 18(2).
Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2.
Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299.
Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5.
Zvyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215, 126(3).
Related Publications (1)
Number Date Country
20220211479 A1 Jul 2022 US
Continuations (3)
Number Date Country
Parent 16436979 Jun 2019 US
Child 17689910 US
Parent 15262165 Sep 2016 US
Child 16436979 US
Parent 14366393 US
Child 15262165 US